Scribd
Upload
1K views5 pages

Januvia's Launch Strategy Insights

Merck developed Januvia, the first in its class drug for treating type 2 diabetes. Januvia reached the market quickly and Merck acquired the related drug Janumet, helping Januvia succeed. Merck also followed a new commercial model and promoted Januvia's benefits like its ease of storage and use as a monotherapy or in combination with other drugs, while its competitor from Novartis was still awaiting FDA approval.

Uploaded by

rinkeshparmar
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
1K views5 pages

Januvia's Launch Strategy Insights

Merck developed Januvia, the first in its class drug for treating type 2 diabetes. Januvia reached the market quickly and Merck acquired the related drug Janumet, helping Januvia succeed. Merck also followed a new commercial model and promoted Januvia's benefits like its ease of storage and use as a monotherapy or in combination with other drugs, while its competitor from Novartis was still awaiting FDA approval.

Uploaded by

rinkeshparmar
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 5

Merck’s New Product Development and

Launch Strategy for Januvia


Made By-: Ankita Joshi
Bhoomika Dhawan
Bhavna Bhanodha
Daisy Goenka
Danish Babuta
Deepika Samtani
Ekta Singh
Gaurav Ahluwalia
Sumedha Bohra
07/02/09 1
Reasons for the success of
Januvia
First in the class drug for the
treatment of Type 2 diabetes.
Speed with which Junavia reached
to the market.
Acquiring another brand Janumet.
Followed new commercial model.

07/02/09 2
Contd……
Can be also used as monotherapy.
Easier to store.
Januvia’s Promotion Strategy.
Competitor Novartis’s drug galvus
still waiting for FDA.

07/02/09 3
07/02/09 4
07/02/09 5

You might also like